TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Dural Arteriovenous Fistulae Treatment Market, by Type
6.1 Introduction
6.2 Type I
6.2.1 Market Estimates & Forecast, 2020- 2027
6.3 Type II
6.3.1 Market Estimates & Forecast, 2020 -2027
6.4 Type III
6.4.1 Market Estimates & Forecast, 2020 -2027ยฌยฌ
Chapter 7. Global Dural Arteriovenous Fistulae Treatment Market, by Treatment
7.1 Introduction
7.2 Surgery
7.2.1 Market Estimates & Forecast, 2020 -2027
7.3 Stereotactic radiosurgery
7.3.1 Market Estimates & Forecast, 2020 -2027
7.4 Embolization
7.4.1 Market Estimates & Forecast, 2020 -2027
Chapter 8. Global Dural Arteriovenous Fistulae Treatment Market, by End User
8.1 Introduction
8.2 Hospitals & Clinics
8.2.1 Market Estimates & Forecast, 2020 -2027
8.3 Ambulatory Surgical Centers
8.2.2 Market Estimates & Forecast, 2020 -2027
8.4 Others
Chapter 9. Global Dural Arteriovenous Fistulae Treatment Market, by Region
9.1 Introduction
9.2 America
9.2.1 North America
9.2.1.1 US
9.2.1.1 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of the Middle East & Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11. Company Profiles
11.1 BD
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 Medtronic
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 B. Braun Melsungen AG
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Cook
11.4.1 Company Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Teleflex Incorporated
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Fresenius Medical Care AG & Co. KGaA
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 NxStage Medical, Inc.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Others
Chapter 12. MRFR Conclusion
12.1 Key Findings
12.1.1 From CEOโs View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Medical Devices industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Dural Arteriovenous Fistulae Treatment Industry Synopsis, 2020 -2027
Table 2 Global Dural Arteriovenous Fistulae Treatment Market Estimates and Forecast, 2020 -2027, (USD Million)
Table 3 Global Dural Arteriovenous Fistulae Treatment Market by Region, 2020 -2027, (USD Million)
Table 4 Global Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)
Table 5 Global Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)
Table 6 Global Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)
Table 7 North America Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)
Table 8 North America Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)
Table 9 North America Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)
Table 10 US Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)
Table 11 US Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)
Table 12 US Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)
Table 13 Canada Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)
Table 14 Canada Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)
Table 15 Canada Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)
Table 16 South America Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)
Table 17 South America Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)
Table 18 South America Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)
Table 19 Europe Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)
Table 20 Europe Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)
Table 21 Europe Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)
Table 22 Western Europe Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)
Table 23 Western Europe Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)
Table 24 Western Europe Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)
Table 25 Eastern Europe Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)
Table 26 Eastern Europe Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)
Table 27 Eastern Europe Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)
Table 28 Asia Pacific Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)
Table 29 Asia Pacific Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)
Table 30 Asia Pacific Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)
Table 31 Middle East & Africa Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)
Table 32 Middle East & Africa Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)
Table 33 Middle East & Africa Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Dural Arteriovenous Fistulae Treatment Market
Figure 3 Segmentation Market Dynamics for Global Dural Arteriovenous Fistulae Treatment Market
Figure 4 Global Dural Arteriovenous Fistulae Treatment market Share, by Type 2020
Figure 5 Global Dural Arteriovenous Fistulae Treatment market Share, by Treatment 2020
Figure 6 Global Dural Arteriovenous Fistulae Treatment Market Share, by End Users, 2020
Figure 7 Global Dural Arteriovenous Fistulae Treatment Market Share, by Region, 2020
Figure 8 North America Dural Arteriovenous Fistulae Treatment Market Share, by Country, 2020
Figure 9 Europe Dural Arteriovenous Fistulae Treatment Market Share, by Country, 2020
Figure 10 Asia Pacific Dural Arteriovenous Fistulae Treatment Market Share, by Country, 2020
Figure 11 Middle East & Africa Dural Arteriovenous Fistulae Treatment Market Share, by Country, 2020
Figure 12 Global Dural Arteriovenous Fistulae Treatment Market: Company Share Analysis, 2020 (%)
Figure 13 BD: Key Financials
Figure 14 BD: Segmental Revenue
Figure 15 BD: Geographical Revenue
Figure 16 Medtronic: Key Financials
Figure 17 Medtronic: Segmental Revenue
Figure 18 Medtronic: Geographical Revenue
Figure 19 B. Braun Melsungen AG: Key Financials
Figure 20 B. Braun Melsungen AG: Segmental Revenue
Figure 21 B. Braun Melsungen AG: Geographical Revenue
Figure 22 Cook: Key Financials
Figure 23 Cook: Segmental Revenue
Figure 24 Cook: Geographical Revenue
Figure 25 Teleflex Incorporated: Key Financials
Figure 26 Teleflex Incorporated: Segmental Revenue
Figure 27 Teleflex Incorporated: Geographical Revenue
Figure 28 Fresenius Medical Care AG & Co. KGaA.: Key Financials
Figure 29 Fresenius Medical Care AG & Co. KGaA: Segmental Revenue
Figure 30 Fresenius Medical Care AG & Co. KGaA.: Geographical Revenue
Figure 31 NxStage Medical, Inc.: Key Financials
Figure 32 NxStage Medical, Inc.: Segmental Revenue
Figure 33 NxStage Medical, Inc.: Geographical Revenue